Advanced

Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon

Rothfield, Naomi; Shapiro, Lee; Fiorentino, David; Chung, Lorinda; Denton, Christopher; Herrick, Ariane; Baron, Murray; Shanahan, Joseph; Hsu, Vivien and Belch, Jill, et al. (2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.821-821
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Arthritis and Rheumatism
volume
58
issue
9
pages
821 - 821
publisher
John Wiley & Sons
conference name
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals
external identifiers
  • wos:000259244202266
ISSN
1529-0131
language
English
LU publication?
yes
id
b1f6af55-1652-43ce-971e-c67ea98f7e3a (old id 1287536)
date added to LUP
2009-02-10 15:03:49
date last changed
2016-04-15 18:51:12
@misc{b1f6af55-1652-43ce-971e-c67ea98f7e3a,
  author       = {Rothfield, Naomi and Shapiro, Lee and Fiorentino, David and Chung, Lorinda and Denton, Christopher and Herrick, Ariane and Baron, Murray and Shanahan, Joseph and Hsu, Vivien and Belch, Jill and Steen, Virginia and Scheja, Agneta and Martin, Richard and Smith, Edwin and Mayes, Maureen and Simms, Robert and Pope, Janet and Kahaleh, Bashar and Csuka, Mary Ellen and Gruber, Barry and Collier, David and Sweiss, Nadera and Sule, Sangeeta and Emery, Paul and Wigey, Fredrick M.},
  issn         = {1529-0131},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {9},
  pages        = {821--821},
  publisher    = {John Wiley & Sons},
  series       = {Arthritis and Rheumatism},
  title        = {Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon},
  volume       = {58},
  year         = {2008},
}